SCHEMBL6462937

SCHEMBL6462937

CC(C)(NC(=O)c1ccc(Br)s1)C(=O)Nc1ccc(N2CCOCC2)c(Cl)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.78
AR P10275 2/20 0.63
RAB9A P51151 9/20 0.52
NPC1 O15118 8/20 0.52
SMN1; SMN2 Q16637 7/20 0.52
MAPT P10636 6/20 0.52
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
ALDH1A1 P00352 5/20 0.52
LMNA P02545 4/20 0.52
HTT P42858 4/20 0.52
HPGD P15428 4/20 0.52
TP53 P04637 2/20 0.52
MAPK1 P28482 1/20 0.51
TSHR P16473 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6455635 0.90 F10 (0.68) F10ARRAB9ANPC1SMN1; SMN2
SCHEMBL4459632 0.89 F10 (0.86) F10ARRAB9ANPC1SMN1; SMN2
SCHEMBL4460992 0.88 F10 (1.00) F10AR
SCHEMBL3423061 0.86 F10 (0.67) F10ARRAB9ANPC1SMN1; SMN2
SCHEMBL6455305 0.86 F10 (0.64) F10ARRAB9ANPC1SMN1; SMN2
SCHEMBL6457953 0.85 F10 (0.68) F10ARRAB9ANPC1SMN1; SMN2
SCHEMBL6455327 0.85 F10 (0.67) F10ARRAB9ANPC1SMN1; SMN2
SCHEMBL13965131 0.84 F10 (0.70) F10ARRAB9ANPC1SMN1; SMN2
SCHEMBL4468098 0.84 F10 (0.70) F10ARRAB9ANPC1SMN1; SMN2
SCHEMBL6454976 0.83 F10 (0.65) F10ARRAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005111013-A1 SUBSTITUTED THIOPHENE-2-CARBOXYLIC ACID AMIDES, THE PRODUCTION THEREOF AND THE USE THEREOF AS DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-24 WO disclosed
US-20050256107-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256107-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments OTC, TPMT, ABCG2 F10 1901/4885AR 3491/4885RAB9A 3277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.